ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 Trial Reaches 50% Recruitment
|
|
diersel
|
7 |
1.3K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
7
|
1.3K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 Trial Reaches 50% Recruitment
|
|
diersel
|
7 |
1.3K |
2 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
7
|
1.3K
|
2
|
|
ASX - By Stock
|
MVP |
Re:
Ann: Change in substantial holding
|
|
diersel
|
26 |
10K |
4 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
26
|
10K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation - quarterly update
|
|
diersel
|
6 |
2.1K |
3 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
6
|
2.1K
|
3
|
|
ASX - By Stock
|
HLS |
Re:
Healius share price unnaturally influenced ?
|
|
diersel
|
9 |
4.5K |
1 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
9
|
4.5K
|
1
|
|
ASX - By Stock
|
MVP |
Re:
Ann: FY23 Full Year Results Announcement Details
|
|
diersel
|
18 |
6.7K |
0 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
18
|
6.7K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Change in substantial holding
|
|
diersel
|
3 |
1.6K |
1 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
3
|
1.6K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor Presentation
|
|
diersel
|
6 |
2.7K |
0 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
6
|
2.7K
|
0
|
|
ASX - By Stock
|
MVP |
Re:
Share price has doubled, no announcements
|
|
diersel
|
85 |
33K |
4 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
85
|
33K
|
4
|
|
ASX - By Stock
|
MVP |
Re:
Green Whistle UK
|
|
diersel
|
194 |
86K |
3 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
194
|
86K
|
3
|
|
ASX - By Stock
|
MVP |
Re:
Green Whistle UK
|
|
diersel
|
194 |
86K |
5 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
194
|
86K
|
5
|
|
ASX - By Stock
|
MVP |
Re:
MVP full year revenue
|
|
diersel
|
38 |
13K |
2 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
38
|
13K
|
2
|
|
ASX - By Stock
|
NXL |
Re:
Ann: ASIC update
|
|
diersel
|
144 |
36K |
1 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
144
|
36K
|
1
|
|
ASX - General
|
|
Re:
SNAS dabbling... a short(ing) journey...
|
|
diersel
|
32 |
10K |
1 |
21/06/21 |
21/06/21 |
ASX - General
|
32
|
10K
|
1
|
|
ASX - General
|
|
Re:
SNAS dabbling... a short(ing) journey...
|
|
diersel
|
32 |
10K |
0 |
18/06/21 |
18/06/21 |
ASX - General
|
32
|
10K
|
0
|
|
ASX - By Stock
|
APX |
Re:
Ann: Response to ASX Price Query
|
|
diersel
|
130 |
74K |
1 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
130
|
74K
|
1
|
|
ASX - By Stock
|
APX |
Re:
Ann: Macquarie Australia Conference
|
|
diersel
|
177 |
81K |
3 |
06/05/21 |
06/05/21 |
ASX - By Stock
|
177
|
81K
|
3
|
|
International Markets
|
SP500 |
Re:
BBUS
|
|
diersel
|
14K |
3.7M |
2 |
30/04/21 |
30/04/21 |
International Markets
|
14K
|
3.7M
|
2
|
|
ASX - By Stock
|
SBM |
Re:
Ann: Quarterly Report Q3 March FY21
|
|
diersel
|
9 |
5.0K |
3 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
9
|
5.0K
|
3
|
|
ASX - By Stock
|
OSH |
Re:
JP Morgan $5.35 Target!
|
|
diersel
|
36 |
15K |
5 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
36
|
15K
|
5
|
|
ASX - By Stock
|
OSH |
Re:
JP Morgan $5.35 Target!
|
|
diersel
|
36 |
15K |
5 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
36
|
15K
|
5
|
|
ASX - By Stock
|
ORG |
Re:
News: ORG Origin Energy Revises FY21 Energy Markets Underlying EBITDA In Range Of $940-$1,020...
|
|
diersel
|
237 |
113K |
5 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
237
|
113K
|
5
|
|
ASX - By Stock
|
MPL |
Credit Suisse Outperform
|
|
diersel
|
2 |
2.0K |
2 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
2
|
2.0K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Daily Price Movement / General Discussion
|
|
diersel
|
46K |
11M |
4 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
46K
|
11M
|
4
|
|
ASX - By Stock
|
TLS |
Re:
Ann: Update - Dividend/Distribution - TLS
|
|
diersel
|
4 |
4.0K |
0 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
4
|
4.0K
|
0
|
|
Charts
|
APX |
Re:
APX Charts
|
|
diersel
|
3.8K |
2.0M |
3 |
05/03/21 |
05/03/21 |
Charts
|
3.8K
|
2.0M
|
3
|
|
ASX - By Stock
|
APX |
Re:
Ann: Appen 2020 Full Year results
|
|
diersel
|
400 |
232K |
2 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
400
|
232K
|
2
|
|
Charts
|
APX |
Re:
APX Charts
|
|
diersel
|
3.8K |
2.0M |
4 |
25/02/21 |
25/02/21 |
Charts
|
3.8K
|
2.0M
|
4
|
|
ASX - By Stock
|
QBE |
Re:
Ann: QBE 2021 Annual General Meeting
|
|
diersel
|
35 |
12K |
0 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
35
|
12K
|
0
|
|
ASX - By Stock
|
ORG |
Re:
Ann: Update on operating conditions and guidance for FY2021
|
|
diersel
|
56 |
20K |
2 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
56
|
20K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
diersel
|
18K |
10M |
1 |
13/01/21 |
13/01/21 |
ASX - By Stock
|
18K
|
10M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
diersel
|
1.0K |
515K |
9 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
1.0K
|
515K
|
9
|
|
ASX - General
|
Managed Funds |
Re:
*** BBOZ - Inverse ASX200 ETF ***
|
|
diersel
|
105 |
142K |
3 |
24/11/20 |
24/11/20 |
ASX - General
|
105
|
142K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Boehringer Ingelheim discontinues development of BI 1467335
|
|
diersel
|
18 |
8.8K |
4 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
18
|
8.8K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Bronchitol NDA Resubmission - FDA Decision Date 1 November
|
|
diersel
|
7 |
4.9K |
1 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
7
|
4.9K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Chiesi Files Resubmission for Bronchitol with FDA
|
|
diersel
|
7 |
3.3K |
0 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
7
|
3.3K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Wakey Wakey Management
|
|
diersel
|
7 |
3.1K |
0 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
7
|
3.1K
|
0
|
|
ASX - By Stock
|
QBE |
Re:
Ann: Trading Halt
|
|
diersel
|
108 |
59K |
3 |
21/04/20 |
21/04/20 |
ASX - By Stock
|
108
|
59K
|
3
|
|
ASX - By Stock
|
SNT |
Upcoming PXS news
|
|
diersel
|
0 |
407 |
5 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
0
|
407
|
5
|
|
ASX - By Stock
|
OSH |
Re:
Could close Gap to $5 very fast now
|
|
diersel
|
291 |
108K |
2 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
291
|
108K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
The hanging buy order
|
|
diersel
|
19 |
23K |
3 |
26/03/20 |
26/03/20 |
ASX - By Stock
|
19
|
23K
|
3
|
|
ASX - By Stock
|
VOC |
Re:
Long-Term progress
|
|
diersel
|
250 |
146K |
3 |
17/03/20 |
17/03/20 |
ASX - By Stock
|
250
|
146K
|
3
|
|
ASX - By Stock
|
EVN |
Re:
EVN chart
|
|
diersel
|
3.5K |
1.4M |
4 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
3.5K
|
1.4M
|
4
|
|
ASX - By Stock
|
NHC |
Re:
Ann: Becoming a substantial holder
|
|
diersel
|
24 |
72K |
2 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
24
|
72K
|
2
|
|
ASX - By Stock
|
SBM |
Re:
Ann: December 2019 Half Year Report and ASX Appendix 4D
|
|
diersel
|
125 |
224K |
3 |
21/02/20 |
21/02/20 |
ASX - By Stock
|
125
|
224K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Bell Potter research on PXS
|
|
diersel
|
2 |
12K |
2 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
2
|
12K
|
2
|
|
ASX - By Stock
|
SNT |
Bell Potter research on PXS
|
|
diersel
|
2 |
12K |
1 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
2
|
12K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
the remaining positives
|
|
diersel
|
29 |
21K |
12 |
13/01/20 |
13/01/20 |
ASX - By Stock
|
29
|
21K
|
12
|
|
ASX - By Stock
|
SNT |
Re:
the remaining positives
|
|
diersel
|
29 |
21K |
5 |
10/01/20 |
10/01/20 |
ASX - By Stock
|
29
|
21K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Boehringer discontinues development of BI 1467335 for NASH
|
|
diersel
|
40 |
26K |
6 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
40
|
26K
|
6
|
|